Search research articles
Contact Us
Filters
Showing results (131-140 of 179) with videos related to
Page
of 18
Sort By:
Human Gene Therapy
|
October 20, 2023
Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells
Leling Xie, Runxia Gu, Xue Yang, et al.
Blood
|
May 1, 2014
TBLR1 fuses to retinoid acid receptor α in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia
Yirui Chen, Shouyun Li, Chunlin Zhou, et al.
Oncotarget
|
April 13, 2017
FHL2 interacts with iASPP and impacts the biological functions of leukemia cells
Wenting Lu, Tengteng Yu, Shuang Liu, et al.
Molecular Oncology
|
July 7, 2025
The critical role of DNA damage-inducible transcript 4 (DDIT4) in stemness character of leukemia cells and leukemia initiation
Yishuang Li, Zhijie Cao, Haiyan Xing, et al.
Oligonucleotides
|
January 21, 2011
Effect of G-rich oligonucleotides on the proliferation of leukemia cells and its relationship with p53 expression
Lei Zhi, Jianwei Zhang, Yujiao Jia, et al.
Oncology Letters
|
September 21, 2017
Regulation of HtrA2 on WT1 gene expression under imatinib stimulation and its effects on the cell biology of K562 cells
Lixia Zhang, Yan Li, Xiaoyan Li, et al.
Current Medical Science
|
July 7, 2025
The Role of the Subnucleus Reticularis Dorsalis (SRD) in Pain Modulation: A Literature Review
Zi-Yan Zhang, Jia-le Mei, Yi-Qing Rao, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
July 15, 2024
A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cells
Zhifeng Yan, Runxia Gu, Haotian Ma, et al.
Journal of Hematology & Oncology
|
May 18, 2019
2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies
Yingxi Xu, Qian Liu, Mengjun Zhong, et al.
Experimental Hematology & Oncology
|
March 23, 2022
A novel and efficient CD22 CAR-T therapy induced a robust antitumor effect in relapsed/refractory leukemia patients when combined with CD19 CAR-T treatment as a sequential therapy
Yu Zhang, Saisai Li, Ying Wang, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 179) with videos related to
Sort By:
Page
of 18
Human Gene Therapy
|
October 20, 2023
Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells
Leling Xie, Runxia Gu, Xue Yang, et al.
Blood
|
May 1, 2014
TBLR1 fuses to retinoid acid receptor α in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia
Yirui Chen, Shouyun Li, Chunlin Zhou, et al.
Oncotarget
|
April 13, 2017
FHL2 interacts with iASPP and impacts the biological functions of leukemia cells
Wenting Lu, Tengteng Yu, Shuang Liu, et al.
Molecular Oncology
|
July 7, 2025
The critical role of DNA damage-inducible transcript 4 (DDIT4) in stemness character of leukemia cells and leukemia initiation
Yishuang Li, Zhijie Cao, Haiyan Xing, et al.
Oligonucleotides
|
January 21, 2011
Effect of G-rich oligonucleotides on the proliferation of leukemia cells and its relationship with p53 expression
Lei Zhi, Jianwei Zhang, Yujiao Jia, et al.
Oncology Letters
|
September 21, 2017
Regulation of HtrA2 on WT1 gene expression under imatinib stimulation and its effects on the cell biology of K562 cells
Lixia Zhang, Yan Li, Xiaoyan Li, et al.
Current Medical Science
|
July 7, 2025
The Role of the Subnucleus Reticularis Dorsalis (SRD) in Pain Modulation: A Literature Review
Zi-Yan Zhang, Jia-le Mei, Yi-Qing Rao, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
July 15, 2024
A dual-targeting approach with anti-IL10R CAR-T cells engineered to release anti-CD33 bispecific antibody in enhancing killing effect on acute myeloid leukemia cells
Zhifeng Yan, Runxia Gu, Haotian Ma, et al.
Journal of Hematology & Oncology
|
May 18, 2019
2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies
Yingxi Xu, Qian Liu, Mengjun Zhong, et al.
Experimental Hematology & Oncology
|
March 23, 2022
A novel and efficient CD22 CAR-T therapy induced a robust antitumor effect in relapsed/refractory leukemia patients when combined with CD19 CAR-T treatment as a sequential therapy
Yu Zhang, Saisai Li, Ying Wang, et al.
Page
of 18